Sentences with phrase «pharmaceutical patents»
"Pharmaceutical patents" refers to exclusive rights granted to inventors of new medicines. These rights allow them to protect their inventions from being copied or made by others, ensuring they have the opportunity to recover the costs of their research and development and make a profit. Full definition
Patent fights are nothing new in the pharmaceutical industry but a new report shows that during 2017 the number of legal battles of pharmaceutical patents increased by 30 percent.
biospace.com
Acting in pharmaceutical patent litigation for various well - known global brands involving blockbuster drugs.
The draft makes clear that the three panelists would like to see a reduction in the 5 - year extensions granted on pharmaceutical patents about to expire.
We understand that many pharmaceutical patent applications relate to active pharmaceutical ingredients that are already known, and we try to protect the superior products that often result.
Do pharmaceutical patents give life - sciences companies an incentive to invest in creating life - saving drugs, or do they just keep their prices high?
Had a phenomenal year, worked on a lot of really, really interesting pharmaceutical patent trials, had just a great experience at the federal court.
An interviewee confirms he is «highly recommended for pharmaceutical patent disputes.»
The Hatch - Waxman Act and the AIA balance exclusive rights of pharmaceutical patent holders with entry of generic competitors.
This blawg «reports on Hatch - Waxman litigation and other pharmaceutical patent cases, as well as regulatory and legislative developments.»
Crist has criticized Canadian «promise» case law for invalidating pharmaceutical patents for lack of utility despite the fact that the medicines at issue were commercially successful.
By raising the bar for invalidating pharmaceutical patents, Edgar says the decision could cause a spike in the price of drugs in Canada.
Paula Bremner — Sim, Lowman, Ashton & Mckay LLP — Paula specializes in pharmaceutical patent litigation and also has significant experience in trade - mark opposition matters.
Lilly claimed that the promise doctrine fundamentally changed Canada's utility requirement, exceeds patentability requirements of trading partners, contravenes Canada's international trade obligations and discriminates against pharmaceutical patents.
The Test has invalidated many pharmaceutical patents (and more recently, non-pharmaceutical patents).
• improving the right of pharmaceutical companies to appeal a loss in certain specialized pharmaceutical patent litigation cases called «NOC proceedings.»
With the implementation of the CETA, as of September 21, 2017, Canadian law now provides for certificates of supplementary protection that extend the term of certain pharmaceutical patents for up to two years.
> when russia started granting pharmaceutical patent (chemical per se) > whether use claims are granted or not?
He would use his old political contacts to shepherd legislation to extend pharmaceutical patents, adding up to seven years of exclusive marketing time for new drugs that had taken too long to get through the FDA approval process.
Canadian pharmaceutical patent owners can expect two substantive changes in the next year following implementation of the Canada — European Union Comprehensive Economic and Trade Agreement («CETA»):
Edgar says pharmaceutical patents were more likely to run into problems with the promise doctrine than in the software and electronic hardware industries where he does most of his patent work.
It scored victories in two Supreme Court cases — both against government agencies — involving fuel gas surcharges calculation and personal data protection, which set the standards for their respective industries, for instance, as well as in multiple disputes related to pharmaceutical patent licensing, invalidation and unfair competition.
The firm further bolstered its IP roster by hiring a six - lawyer group of pharmaceutical patent litigators led by John North from Sutherland Asbill & Brennan in Atlanta.
He practices commercial and intellectual property litigation in a variety of disciplines, including pharmaceutical patent litigation and Hatch - Waxman litigation.
As we reported, Canada implemented a single - track pharmaceutical patent litigation regime through amendments to the Patented Medicines (Notice of Compliance) Regulations (the Regulations) on September 21, 2017.
Served as an appellate judge in the mock argument of a case before the Federal Circuit involving pharmaceutical patents
Under the latter, Canada will, first, provide up to two years of supplementary protection to pharmaceutical patents due to delays in excess of five years between patent filing and market approval.
CETA impacts trademark law and pharmaceutical patent law, among other things, in Canada.
Secondly, there may very well be practical concerns at play that mean pharmaceutical patents are particularly susceptible to the Promise doctrine.
Defeated summary judgment of obviousness and summary judgment of lack of enablement in multi-defendant pharmaceutical patent litigations.
He has written extensively on pharmaceutical patents, parallel importation, antitrust law, commercialization and other uses of data, and the role of intellectual property policy in shaping these diverse areas.
In a statement, The Council of Canadians points out the EU language was adopted on resolution of pharmaceutical patent disputes.
Under the modifications, pharmaceutical patent holders will benefit from a two - year automatic stay on the issuance of market approval to generics, but the stay will not be extended to appeal should the patent holder lose.
Although it is true that many patents, particularly in the pharmaceutical field, have been found invalid on this basis, it is also true that many pharmaceutical patents have been found valid and infringed, a point Crist conveniently ignores.
I mean when russia started granting pharmaceutical patent (chemical per se) whether use claims are granted or not?
On September 23, Canada's Competition Bureau («the Bureau») announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada's competition law framework.
Industrialized countries have been vocal in promoting trade openness in these areas and have fiercely defended the need to respect and enforce intellectual property rights (e.g., pharmaceutical patents and software).
On 2 April, a draft report on pharmaceutical patents that calls for limiting the reach of intellectual property (IP) was unveiled.
(As an aside, while NAFTA did change the compulsory licensing regime with respect to pharmaceutical patents, S. 66 (1)(a) of the patent act still allows for compulsory licensing in some situations (in theory at least, I don't know of any examples in practice).
The PM (NOC) Regulations provide innovators of pharmaceutical patents («innovator») with an ability to list their patents on a Patent List.
After focusing on pharmaceutical patent and trade - mark litigation for most of her career, Paula now advises on IP strategy in the biotech sector.
She has extensive experience trying large - scale patent litigation, nationally and internationally, relating to pharmaceutical patents and is currently lead trial counsel in several Hatch - Waxman cases.
At first glance, a pharmaceutical patent application may be considered as just another chemical patent application, but we believe that a pharmaceutical patent application needs to be drafted differently than a chemical application, with an emphasis on protecting the final pharmaceutical product that is administered to a patient, and we're able to do that with our knowledge on pharmaceutical law.
In a statement, Jim Keon, president of the Canadian Generic Pharmaceutical Association, said: «While the specific implementation details will be crucial to the success of these critical reforms, CGPA welcomes the Government of Canada's commitment to reduce the burden on the courts, bring earlier finality to pharmaceutical patent disputes, and deliver greater business certainty for generic pharmaceutical companies in Canada.»
For all the organized bar's contempt for paralegals, your average solo in Wawa, Glace Bay or Trail has a lot more in common with the local paralegal than he or she does with a pharmaceutical patent lawyer in Ottawa, a tax litigator in Vancouver, or an oil - and - gas dealmaker in Halifax.
In cases involving the Hatch - Waxman Act and issues involving the expiration of pharmaceutical patents and competition between branded drug companies and generic manufacturers, our antitrust litigation graphics can illuminate a complicated industry and a complex regulatory scheme as below:
In Canada, pharmaceutical patent disputes dominate the Federal Court's intellectual property docket in light of the country's unique legal framework governing pharmaceutical patents.